This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Yatao Qiu: Innovator in Heterocyclic Urea Compounds
Introduction
Yatao Qiu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compositions. His work focuses on addressing critical challenges in immunological therapy.
Latest Patents
Yatao Qiu holds 1 patent for his invention titled "Heterocyclic urea compound, and drug composition and application thereof." This patent specifically discloses an indoleamine-2,3-dioxygenase inhibitor derived from a heterocyclic urea compound. The invention aims to resolve issues related to the weak curative effects and the larger toxic and side effects associated with existing immunological therapy drugs. Furthermore, it provides a preparation method for this inhibitor and outlines its application in developing drugs for treating or preventing tumors.
Career Highlights
Yatao Qiu is affiliated with China Pharmaceutical University, where he continues to advance his research and innovation in drug development. His work has garnered attention for its potential impact on cancer treatment and immunotherapy.
Collaborations
Yatao Qiu collaborates with notable colleagues, including Sheng Jiang and Zhengchao Tu, who contribute to his research endeavors and enhance the scope of his projects.
Conclusion
Yatao Qiu's innovative work in the field of heterocyclic urea compounds represents a significant advancement in pharmaceutical research. His contributions have the potential to improve therapeutic outcomes for patients undergoing immunological treatments.